Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Cilengitide

EU orphan designation number: EU/3/03/184
Active ingredient: Cilengitide
Indication: Treatment of glioma
Sponsor: Merck KGaA
Frankfurter Straße 250, 64293 Darmstadt, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/01/2004 Orphan designation EMEA/OD/067/03 (2003)97 of 14/01/2004
12/03/2013 Removal of orphan designation from Community Register